Supplier
ZENTIVA FRANCE
PARIS · FRA
Track this recordFree account — get alerted when a contract here runs out.
Awards
6
Total awarded
€21.1m
6 / 6 with a value
Buyers
4
Sectors
1
Reg. 40771047400047
Contracts this supplier holds that are running out
24 Mar 2027
estimatedDALBAVANCINE - POUDRE POUR SOLUTION INJECTABLE€161,550Centre Hospitalier de l'Agglomération de NeversZENTIVA FRANCE
- €1,169,391
2 Aug 2027
estimated - €19,589,370
2 Aug 2027
estimated - €21,956
30 Apr 2029
stated - €22,061
30 Apr 2029
stated
Awards
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| DALBAVANCINE CHLORHYDRATE | Centre Hospitalier de Valenciennes | ZENTIVA FRANCE | €19,589,370 | 28 Aug 2026 |
| LACOSAMIDE FORME INJECTABLE | Centre Hospitalier de Valenciennes | ZENTIVA FRANCE | €1,169,391 | 28 Aug 2026 |
| V03AF04 - LEVOFOLINATE DE CALCIUM 10 MG/ML | GIP RESAH | ZENTIVA FRANCE | €22,061 | 3 Apr 2026 |
| DALBAVANCINE - POUDRE POUR SOLUTION INJECTABLE | Centre Hospitalier de l'Agglomération de Nevers | ZENTIVA FRANCE | €161,550 | 26 Mar 2026 |
| PACLITAXEL ALBUMINE | CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR | ZENTIVA FRANCE | €148,200 | 30 May 2025 |
| LOT 31 - L01XX41- ERIBULINE | GIP RESAH | ZENTIVA FRANCE | €21,956 | 26 May 2025 |